RT
Relmada Therapeutics, Inc. - Common Stock
RLMD
Close · 10/09/2026
4.07
1D
-0.49%52-week range
1.44 – 8
Volume
28,09,000.00
Price history
RLMD
11/08/2026 to 10/09/2026
O 4.25 H 4.25 L 4.00
1W-10.35%
1M-8.95%
3M-36.21%
6M-35.60%
1Y+160.90%
3Y+7.67%
5Y-83.07%
MAX-87.40%
Fundamentals
as of 10/09/2026- Market cap
- $434.15M
- Shares out
- 106.67M
- P/E (forward)
- -7.91
- EPS (trailing)
- -0.58
- Profit margin
- 0.00%
- P/B
- 2.10
- Return on equity
- -29.98%
SEC financial statements
49 quarterly and 16 annual periods through 30/06/2026.
Details
- Ticker
- RLMD
- Index
- -
- Sector
- -
- Industry
- -
- HQ
- -
Last close 10/09/2026.
Tracked by Congress
1 filer · 0 on watchlist · 1 buy · 1 sell · ?: 2
- 12/12/2022Christopher L. JacobsSellRelmada Therapeutics, Inc.$1,001–$15,000
- 08/11/2022Christopher L. JacobsBuyRelmada Therapeutics, Inc.$1,001–$15,000